Achieve Life Sciences, Inc.
€4.444
EUR
Last updated on --.
24h volume766.27K
24h highest4.6047 EUR
24h lowest4.3400 EUR
24h Price movement-3.21%
ACHV recent prices
24 Hours
-3.21%-€0.14756
30 days
+5.95%+€0.24738
60 days
+58.59%+€1.627
90 days
+20.26%+€0.74214
Key data
Previous close4.5917 EUR
Market cap466.93M EUR
Volume766.27K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.44268 EUR
Net income (FY)-45.13M EUR
Revenue (FY)--
Last report dateMay 12, 2026
About Achieve Life Sciences, Inc.
HeadquartersSEATTLE
Employees (FY)28.00
Net income per employee (FY)-1.61M EUR
Listed onNasdaq
ACHV conversion tables
 |  |
|---|---|
| 0.5 ACHV | 2.222 EUR |
| 1 ACHV | 4.444 EUR |
| 5 ACHV | 22.22 EUR |
| 10 ACHV | 44.44 EUR |
| |
|---|---|
| 0.5 EUR | 0.11251 ACHV |
| 1 EUR | 0.22501 ACHV |
| 5 EUR | 1.125 ACHV |
| 10 EUR | 2.250 ACHV |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ACHV is trading at €4.444, -3.21% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ACHV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ACHV is currently trading at €4.444, -3.21% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ACHV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ACHV's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ACHV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ACHV's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Achieve Life Sciences, Inc.'s market cap is currently 466.93M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume766.27K
24h highest4.6047 EUR
24h lowest4.3400 EUR
24h Price movement-3.21%
Start trade with ACHV Perpetual
Sign up to trade